Suggestions for prevention of adverse reactions after intravasal administration of iodinated contrast media;Empfehlungen zur Prophylaxe der Nebenwirkungen bei intravasaler Applikation jodhaltiger Kontrastmittel

Rontgenpraxis

Volumn 56, Issue 6, 2008, Pages 199-206

  Kuefner, Michael A ^a   Heinrich, Marc ^a   Bautz, Werner ^a   Uder, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CORTICOSTEROID DERIVATIVE; CREATININE; HISTAMINE AGONIST; IODINATED CONTRAST MEDIUM; METFORMIN;

ANAPHYLAXIS; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG FATALITY; DRUG SAFETY; HUMAN; HYDRATION; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; PROPHYLAXIS; RISK FACTOR; THYROTOXICOSIS;

ADRENAL CORTEX HORMONES; ANAPHYLAXIS; ANIMALS; CONTRAST MEDIA; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; HYPOGLYCEMIC AGENTS; IODINE COMPOUNDS; KIDNEY DISEASES; META-ANALYSIS AS TOPIC; METFORMIN; MICE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; THYROTOXICOSIS; TIME FACTORS;

EID: 44649143841     PISSN: 00357820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rontge.2008.03.001     Document Type: Article

References (43)

1. Thomsen H.S. Guidelines for contrast media from the European Society of Urogenital Radiology. Am J Roentgenol 81 (2003) 1463-1471
2. Thomsen H.S., and Morcos S.K. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 76 (2003) 513-518
3. Nash K., Hafeez A., and Hou S. Hospital-acquired renal insufficiency. Am J Kidney Diseases 39 (2002) 930-936
4. Lin J., and Bonventre J.V. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertension 14 (2005) 105-110
5. Morcos S.K. Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 71 (1998) 357-365
6. Uder M., Heinrich M., Jansen A., Humke U., Utz J., Trautwein W., et al. cAMP and cGMP do not mediate the vasorelaxation induced by iodinated radiographic contrast media in isolated swine renal arteries. Acta Radiol 43 (2002) 104-110
7. Heinrich M., Schneider G., Grgic A., Humke U., Kramann B., and Uder M. Effects of dimeric radiographic contrast medium iotrolan on Swine renal arteries: comparison with monomeric contrast media iohexol and iomeprol. Invest Radiol 39 (2004) 406-412
8. Heinrich M., Kuhlmann M.K., Grgic A., Heckmann M., Kramann B., and Uder M. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology 235 (2005) 843-849
9. Heinrich M., Uder M., and Gleeson T. Pathogenesis of contrast-induced nephropathy. Am J Roentgenol 185 (2005) 1079
10. Uder M., and Heinrich M. Vascular reactions of iodinated X-ray contrast media: mechanisms and possible therapeutic interventions. Anti-Inflammatory Anti-Allergy Agents Med Chem 5 (2006) 129-137
11. Heinrich M., Scheer M., Heckmann M., Bautz W., and Uder M. Reversibility and time-dependency of contrast medium induced inhibition of MTT-conversion in renal proximal tubular cells in vitro: comparison of a monomeric and a dimeric nonionic iodinated contrast medium. Invest Radiol 42 (2007) 732-738
12. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
13. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
14. Heinrich M., and Uder M. Hydrierung zur Prävention der kontrastmittel-induzierten Nephropathie: Ein Update. RöFo 178 (2006) 378-384
15. Hoffmann U., Fischereder M., Kruger B., Drobnik W., and Kramer B.K. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15 (2004) 407-410
16. Trivedi H.S., Moore H., Nasr S., Aggarwal K., Goel P., and Hewett J. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93 (2003) C29-C34
17. Mueller C., Buerkle G., Buettner H.J., Petersen J., Perruchoud A.P., Eriksson U., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162 (2002) 329-336
18. Bader B.D., Berger E.D., Heede M.B., Silberbaur I., Duda S., Risler T., et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?. Clin Nephrol 62 (2004) 1-7
19. Krasuski R.A., Beard B.M., Geoghagan J.D., Thompson C.M., and Guidera S.A. Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. J Invasive Cardiol 15 (2003) 699-702
20. Taylor A.J., Hotchkiss D., Morse R.W., and McCabe J. PREPARED: preparation for angiography in renal dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 114 (1998) 1570-1574
21. Heinrich M., Kuhlmann M.K., Kohlbacher S., Scheer M., Grgic A., Heckmann M., et al. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study. Radiology 242 (2007) 425-434
22. Heinrich M., and Uder M. Nephrogene systemische Fibrose nach Anwendung gadoliniumhaltiger Kontrastmittel - Ein Statuspapier zum aktuellen Stand des Wissens. RöFo 179 (2007) 613-617
23. Thomsen H.S., and Morcos S.K. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee. Eur Radiol 9 (1999) 738-740
24. Sirtori C.R., and Pasi C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 30 (1994) 187-228
25. McCartney M.M., Gilbert F.J., Murchison L.E., Pearson D., McHardy K., and Murray A.D. Metformin and contrast media - a dangerous combination?. Clin Radiol 54 (1999) 29-33
26. ESUR guideline on contrast media version 6.0. 〈www.esur.org/ESUR_Guidelines_New.6.0.html〉.
27. Rendl J., and Saller B. Schilddrüse und Röntgenkontrastmittel: Pathophysiologie, Häufigkeit und Prophylaxe der jodinduzierten Hyperthyreose. Deutsches Ärzteblatt 98 (2001) A402-A406
28. Hintze G., Blombach O., Fink H., Burkhardt U., and Kobberling J. Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. Eur J Endocrinol 140 (1999) 264-267
29. Nolte W., Muller R., Siggelkow H., Emrich D., and Hufner M. Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur J Endocrinol 134 (1996) 337-341
30. de Bruin T.W. Iodide-induced hyperthyroidism with computed tomography contrast fluids. Lancet 343 (1994) 1160-1161
31. Schumm-Draeger P.M., Usadel K.H., Senekowitsch R., et al. Effekt einer thyreostatischen Therapie bei iodinduzierter Hyperthyreose - Untersuchungen an xenotransplantierten Geweben immunogener sowie nichtimmunogener Hyperthyreoseformen. In: Pickardt C.R., Pfannenstiel P., and Weinheimer B. (Eds). Schilddrüse 1987 (1989), Thieme Verlag, Stuttgart, New York 253-258
32. Meyer-Gessner M., Benker G., Olbricht T., Windeck R., Cissewski K., Reiner C., et al. Nebenwirkungen der antithyreoidalen Therapie der Hyperthyreose. Deutsche Medizinische Wochenschrift 114 (1989) 166-171
33. Ring J., and Behrendt H. Anaphylaxis and anaphylactoid reactions. Classification and Pathophysiology. Clin Rev Allergy Immunol 17 (1999) 387-399
34. Christiansen C. X-ray contrast media - an overview. Toxicology 209 (2005) 185-187
35. Idee J.M., Pines E., Prigent P., and Corot C. Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol 19 (2005) 263-281
36. Morcos S.K. Review article: acute serious and fatal reactions to contrast media: our current understanding. Br J Radiol 78 (2005) 686-693
37. Laroche D., Aimone-Gastin I., Dubois F., Huet H., Gerard P., Vergnaud M.C., et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 209 (1998) 183-190
38. Eloy R., Corot C., and Belleville J. Contrast media for angiography: physicochemical properties, pharmacokinetics and biocompatibility. Clin Mater 7 (1991) 89-197
39. Ansell G. Complications of intravascular iodinated contrast media. In: Ansell G., Bettmann M.A., Kaufman J.A., and Wilkins R.A. (Eds). Complications in diagnostic imaging and interventional radiology (1996), Blackwell Science Inc., Boston, MA 245-300
40. Walker A.C., and Carr D.H. Reactions to radiographic contrast media: an attempt to detect specific anti-contrast medium antibodies in the sera of reactor patients. Br J Radiol 59 (1986) 531-536
41. Lasser E.C., Berry C.C., Talner L.B., Santini L.C., Lang E.K., Gerbner F.H., et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. New Engl J Med 317 (1987) 845-849
42. Lasser E.C., Berry C.C., Mishkin M.M., Williamson B., Zheutlin N., and Silverman J.M. Pretreatment with corticosteroids to prevent adverse reactions to non-ionic contrast media. Am J Roentgenol 162 (1994) 523-526
43. Bettmann M.A. Frequently asked questions: iodinated contrast agenst. Radiographics 24 (2004) S3-S10